In non-small cell lung cancer (NSCLC) expression of FRAT1 correlates with β-catenin expression and is associated with tumor differentiation, tumor stage and lymph node metastasis [38, 39]. This evidence concerns the gene FRAT1 and metastatic malignant neoplasm in the lymph nodes.